Corryn Biotechnologies was proud to attend the Royal Academy of Engineering's Enterprise Hub Summer Showcase 2022. As part of the event we were privileged (and challenged!) to pitch in front of our Enterprise Hub colleagues, key angel and corporate investors, as well as leading figures from a range of engineering fields from the UK and beyond.

Corryn Biotechnologies is the latest member of MediWales - the life science network for Wales. With over 180 members from the medical technology, diagnostic and pharmaceutical industries, NHS health boards, university departments and professional services and suppliers, Corryn looks forward to collaborating with, and contributing to, the thriving medical device ecosystem in Wales and the UK.

Corryn Biotechnologies will continue to support cutting-edge research in redistributed manufacturing for healthcare through a new collaboration with the University of the West of England's Faculty of Environment and Technology. This project will develop tailored testing and analysis protocols for our devies in real-world conditions, to improve process stability and ensure an excellent user experience.

Everyone at Corryn is delighted to hear that the Royal Academy of Engineering's Enterprise Fellowship has been ranked as one of the UK's top 10 accelerators by Sifted EU in conjunction with Beauhurst. As a member of the Fellowship since July 2021 we're very proud that the exceptional Enterprise Hub team as well as the hubs innovative members have been recognised.

Corryn Biotechnologies is excited to announce that our founder Dr Luke Burke has received the Royal Academy of Engineering's Enterprise Fellowship to develop Corryn Biotechnologies Ltd. This award provides £60,000 in non-equity funding for business development, along with specialised training, mentorship, and access to the Royal Academy's extensive networks and expertise.

Corryn Biotechnologies Ltd will receive up to £20,000 in support funding from the AgorIP project for commercialisation, intellectual property protection, account and business support, and development of core technologies. Thanks to EU and Welsh Government support, AgorIP will help Corryn to realise the potential of handheld electrospinning devices in chronic wound treatment and beyond.

Corryn Biotechnologies is partnering with leading researchers at Swansea University to develop core handheld electrospinning technologies for wound treatment. This EPSRC reseearch grant, worth £62,000, will assist in researching our prototype systems and developing our materials library. as well as providing connections with experienced frontline medical personnel and key researchers within the growing field of redistributed manufacturing in healthcare.

Founder of Corryn Biotechnologies, Dr Luke Burke will be presenting the advantages and challenges of point-of-care manufacturing systems in general, and as they apply to electrospun wound dressings. We'd be happy to see you there or, if you miss it, Luke's slides will be available on the RiHN website linked here.

Although we do our best to keep this news page up to date, we appreciate there may be specific information or enquiries not covered here. In this case, feel free to contact the team at info@corryn.co.uk and we will do our best to answer any questions you may have about our technology, progress, or the amounts of coffee consumed to build this webpage!